Search

Weiping Zhu

Examiner (ID: 5897, Phone: (571)272-6725 , Office: P/1733 )

Most Active Art Unit
1733
Art Unit(s)
1742, 1793, 1734, 1733
Total Applications
1183
Issued Applications
606
Pending Applications
6
Abandoned Applications
574

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18771226 [patent_doc_number] => 20230366042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => DNA NANODEVICE HINGE BIOSENSORS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/029770 [patent_app_country] => US [patent_app_date] => 2021-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19767 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029770 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/029770
DNA NANODEVICE HINGE BIOSENSORS AND METHODS OF USE THEREOF Sep 30, 2021 Pending
Array ( [id] => 17735099 [patent_doc_number] => 20220220558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => METHODS AND SYSTEMS FOR PROGNOSIS OF A PATIENT'S RESPONSE TO TREATMENT OF ANDROGENETIC SKIN DISORDERS [patent_app_type] => utility [patent_app_number] => 17/491134 [patent_app_country] => US [patent_app_date] => 2021-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8286 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491134 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/491134
METHODS AND SYSTEMS FOR PROGNOSIS OF A PATIENT'S RESPONSE TO TREATMENT OF ANDROGENETIC SKIN DISORDERS Sep 29, 2021 Abandoned
Array ( [id] => 17612006 [patent_doc_number] => 20220154285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => ANALYSIS OF METHYLATED DNA COMPRISING METHYLATION-SENSITIVE OR METHYLATION-DEPENDENT RESTRICTIONS [patent_app_type] => utility [patent_app_number] => 17/489687 [patent_app_country] => US [patent_app_date] => 2021-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47736 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489687 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/489687
ANALYSIS OF METHYLATED DNA COMPRISING METHYLATION-SENSITIVE OR METHYLATION-DEPENDENT RESTRICTIONS Sep 28, 2021 Pending
Array ( [id] => 17627655 [patent_doc_number] => 20220162670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => METHODS AND SYSTEMS TO IMPROVE THE SIGNAL TO NOISE RATIO OF DNA METHYLATION PARTITIONING ASSAYS [patent_app_type] => utility [patent_app_number] => 17/489677 [patent_app_country] => US [patent_app_date] => 2021-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56642 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489677 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/489677
METHODS AND SYSTEMS TO IMPROVE THE SIGNAL TO NOISE RATIO OF DNA METHYLATION PARTITIONING ASSAYS Sep 28, 2021 Pending
Array ( [id] => 20302667 [patent_doc_number] => 12448646 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-21 [patent_title] => SSB method [patent_app_type] => utility [patent_app_number] => 17/481374 [patent_app_country] => US [patent_app_date] => 2021-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 30285 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17481374 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/481374
SSB method Sep 21, 2021 Issued
Array ( [id] => 17344054 [patent_doc_number] => 20220010385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS [patent_app_type] => utility [patent_app_number] => 17/474334 [patent_app_country] => US [patent_app_date] => 2021-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28514 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474334 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/474334
METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS Sep 13, 2021 Pending
Array ( [id] => 17520794 [patent_doc_number] => 20220106643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => METHODS FOR DETERMINING THE QUALITY OF AN EMBRYO [patent_app_type] => utility [patent_app_number] => 17/472848 [patent_app_country] => US [patent_app_date] => 2021-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7495 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472848 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/472848
METHODS FOR DETERMINING THE QUALITY OF AN EMBRYO Sep 12, 2021 Abandoned
Array ( [id] => 19091191 [patent_doc_number] => 11952623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-09 [patent_title] => Simultaneous determination of aneuploidy and fetal fraction [patent_app_type] => utility [patent_app_number] => 17/465163 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 32479 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 397 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465163 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/465163
Simultaneous determination of aneuploidy and fetal fraction Sep 1, 2021 Issued
Array ( [id] => 17563533 [patent_doc_number] => 20220127682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => SELECTION AND TREATMENT OF CANCER WITH COMBINATION THERAPIES [patent_app_type] => utility [patent_app_number] => 17/459477 [patent_app_country] => US [patent_app_date] => 2021-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39124 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17459477 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/459477
SELECTION AND TREATMENT OF CANCER WITH COMBINATION THERAPIES Aug 26, 2021 Abandoned
Array ( [id] => 18844998 [patent_doc_number] => 20230407402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => PREDICTION OF A RESPONSE OF A PROSTATE CANCER SUBJECT TO THERAPY OR PERSONALIZATION OF THERAPY OF A PROSTATE CANCER SUBJECT [patent_app_type] => utility [patent_app_number] => 18/023598 [patent_app_country] => US [patent_app_date] => 2021-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31620 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023598 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/023598
PREDICTION OF A RESPONSE OF A PROSTATE CANCER SUBJECT TO THERAPY OR PERSONALIZATION OF THERAPY OF A PROSTATE CANCER SUBJECT Aug 23, 2021 Pending
Array ( [id] => 17258952 [patent_doc_number] => 20210371937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => METHOD FOR IDENTIFYING HIGH-RISK AML PATIENTS [patent_app_type] => utility [patent_app_number] => 17/395244 [patent_app_country] => US [patent_app_date] => 2021-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17395244 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/395244
METHOD FOR IDENTIFYING HIGH-RISK AML PATIENTS Aug 4, 2021 Abandoned
Array ( [id] => 17482703 [patent_doc_number] => 20220090207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE [patent_app_type] => utility [patent_app_number] => 17/384251 [patent_app_country] => US [patent_app_date] => 2021-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48080 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384251 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/384251
DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE Jul 22, 2021 Pending
Array ( [id] => 17357176 [patent_doc_number] => 20220017972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS [patent_app_type] => utility [patent_app_number] => 17/381272 [patent_app_country] => US [patent_app_date] => 2021-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10288 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17381272 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/381272
METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS Jul 20, 2021 Abandoned
Array ( [id] => 18658103 [patent_doc_number] => 20230304091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => MINIMALLY INVASIVE KIT FOR DIAGNOSING SKIN CONDITION, COMPRISING MICRONEEDLE PATCH [patent_app_type] => utility [patent_app_number] => 18/020846 [patent_app_country] => US [patent_app_date] => 2021-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26639 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020846 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/020846
MINIMALLY INVASIVE KIT FOR DIAGNOSING SKIN CONDITION, COMPRISING MICRONEEDLE PATCH Jul 19, 2021 Pending
Array ( [id] => 18597683 [patent_doc_number] => 20230272480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => Methods for Classifying Cancer [patent_app_type] => utility [patent_app_number] => 18/015989 [patent_app_country] => US [patent_app_date] => 2021-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12613 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015989 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/015989
Methods for Classifying Cancer Jul 14, 2021 Pending
Array ( [id] => 17370383 [patent_doc_number] => 20220025435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => METHODS AND SYSTEMS FOR ENRICHMENT OF BARCODES [patent_app_type] => utility [patent_app_number] => 17/366248 [patent_app_country] => US [patent_app_date] => 2021-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31814 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366248 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/366248
METHODS AND SYSTEMS FOR ENRICHMENT OF BARCODES Jul 1, 2021 Abandoned
Array ( [id] => 18612766 [patent_doc_number] => 20230279502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => IDENTIFICATION OF ESTROGEN RECEPTOR POSITIVE (ER+) BREAST CANCERS THAT WILL NOT DEVELOP TAMOXIFEN RESISTANCE [patent_app_type] => utility [patent_app_number] => 18/013368 [patent_app_country] => US [patent_app_date] => 2021-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26283 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013368 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/013368
IDENTIFICATION OF ESTROGEN RECEPTOR POSITIVE (ER+) BREAST CANCERS THAT WILL NOT DEVELOP TAMOXIFEN RESISTANCE Jun 28, 2021 Pending
Array ( [id] => 18537892 [patent_doc_number] => 20230242995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => METHOD FOR DETECTING COLORECTAL CANCER [patent_app_type] => utility [patent_app_number] => 18/013178 [patent_app_country] => US [patent_app_date] => 2021-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11431 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013178 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/013178
METHOD FOR DETECTING COLORECTAL CANCER Jun 28, 2021 Pending
Array ( [id] => 17185538 [patent_doc_number] => 20210332423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => HIGHLY STABLE AND SPECIFIC MOLECULAR BEACONS ENCAPSULATED IN CATIONIC LIPOPLEX NANOPARTICLES AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/357862 [patent_app_country] => US [patent_app_date] => 2021-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7928 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357862 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/357862
Highly stable and specific molecular beacons encapsulated in cationic lipoplex nanoparticles and application thereof Jun 23, 2021 Issued
Array ( [id] => 18538709 [patent_doc_number] => 20230243813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => METHODS FOR SELECTING AND TREATING CANCER WITH FGFR3 INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/002076 [patent_app_country] => US [patent_app_date] => 2021-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52783 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -90 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002076 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/002076
METHODS FOR SELECTING AND TREATING CANCER WITH FGFR3 INHIBITORS Jun 21, 2021 Pending
Menu